Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Neha Panjwani

HISTORICAL FACTS: 3 biotech buys under 15 | History Defined

The biotech industry is primed for robust expansion, owing to increased investments in research and development, incorporation of advanced technologies, and growing demand for personalized medicine.

Given this backdrop, fundamentally strong biotech stocks Dynavax Technologies Corporation (DVAX), Entrada Therapeutics, Inc. (TRDA), and Shionogi & Co., Ltd. (SGIOY), trading under $15, could be solid buys now.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.